OXUROxurion NV
0.0028EUR0.00%Mkt Cap: 428323 $P/E:

Oxurion NV, a biopharmaceutical company, develops medicines for vascular retinal disorder in Belgium. The company is developing ophthalmic treatments to preserve vision for patients geographic atrophy and wet age-related…

Key Statistics

Company
Market Cap428.32K $
Enterprise Value12.46M $
Revenue (TTM)603.26K $
Gross Profit603.26K $
Net Income (TTM)-4.05M $
Revenue/Share0.0217 USD
Last Price0.0028 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees26
CountryBE
SectorHealthcare
IndustryBiotechnology
ISINBE0003846632
Valuation
P/E (Trailing)
P/E (Forward)-0.01
PEG
EV/EBITDA-3.52
EV/Revenue20.65
P/S0.71
P/B-0.01
EPS (TTM)-0.13
EPS (Forward)-0.47
52W Range
0.00203% of range0.0268
52W High0.0268 EUR
52W Low0.0020 EUR
Profitability
Gross Margin100.00%
Oper. Margin-269.73%
EBITDA Margin0.00%
Profit Margin-671.71%
ROE28.92%
ROA-97.46%
Growth
Revenue Growth27650.00%
Earnings Growth
Cash Flow & Leverage
Operating CF-1.85M $
CapEx (TTM)
FCF Margin-147.93%
FCF Yield-208.35%
Net Debt11.97M $
Net Debt/EBITDA-3.38
Balance Sheet
Debt/Equity-0.89
Current Ratio0.11
Quick Ratio0.11
Book Value/Sh-0.2060 EUR
Cash/Share0.0050 EUR
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 EUR
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:10000
Split DateSep 3, 2024
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.140.73M
Float87.44M
Insiders21.09%
Institutions0.00%
Technical
SMA 500.0028 (-1.1%)
SMA 2000.0054 (-48.1%)
Beta-0.11
S&P 52W Chg18.16%
Avg Vol (30d)403.06K
Avg Vol (10d)228.92K
Technical Indicators
RSI (14)53.2
MACD-0.0000
MACD Signal-0.0001
MACD Hist.+0.0000
BB Upper0.0029 EUR
BB Middle0.0026 EUR
BB Lower0.0023 EUR
BB Width21.93%
ATR (14)0.0002 EUR
Vol Ratio (20d)0.36x